Empowered Funds, LLC Repligen Corp Transaction History

Empowered Funds, LLC

  • $6.59 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$165.87 - $220.95 $1.54 Million - $2.05 Million
-9,284 Closed
0 $0
Q4 2020

Feb 02, 2021
BUY
$148.08 - $206.57 $1.37 Million - $1.92 Million
9,284 New
9,284 $1.78 Million
Q3 2020

Oct 26, 2020
SELL
$122.51 - $158.27 $1.18 Million - $1.52 Million
-9,621 Closed
0 $0
Q2 2020

Jul 16, 2020
BUY
$94.33 - $140.48 $907,548 - $1.35 Million
9,621 New
9,621 $1.19 Million

Others Institutions Holding RGEN

# of Institutions
481
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.82B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email